The UK is a global leader in clinical trials; there is an understanding among healthcare professionals, patients, government and administrators that well-run trials offer a win-win-win solution – innovative treatment for patients, cost savings for the health service and increased scientific knowledge. In the UK, the National Institute for Health Research (NIHR)is committed to promoting faster, easier clinical research through unified, streamlined and simple systems for managing ethical research and its outputs, as well as providing the facilities and people needed for a thriving research environment. The NIHR's campaign, OK to Ask, shows the value of communicating the benefits of clinical trials to patients, and offers a practical blueprint for health services in other countries.
Poland an important market for AstraZeneca, where it has invested significantly in an R&D hub. Improvements in the way clinical trials are perceived by the government, healthcare institutions and patients, will increase the effectiveness of its R&D operations in Poland.
Agenda:
09:30-10:00 Registration, coffee
10:00-10:15
Opening and welcome
Her Majesty's Ambassador, Robin Barnett;
BPCC Chairman, Antoni F. Reczek
10:15-10:45 Keynote address – Dr Jonathan Sheffield, CEO, NIHR
10:45-11:30
Clinical trials – the Polish experience:
Representative of Polish Ministry of Health (TBC)
Representative of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (TBC)
Prof. Jan Lubiński, Pomorski Uniwersytet Medyczny w Szczecinie, Read-Gene S.A. – Investigator’s point of view
11:30-12:00 Creating the optimal environment for conducting clinical trials – the UK perspective, Sophie Gillmore, Clinical Research Manager, GMD, SMM Region Europe Middle East & Africa, AstraZeneca UK
12:00-12:15 Coffee break
12:15-12:35 Practical issues facing pharmaceutical firms conducting clinical trials in Poland – Marcin Borycki, Dyrektor ds. Badań Klinicznych, GMD, SMM Region Europe, Middle East & Africa, AstraZeneca Pharma Poland sp. z o.o.
12:35-13:30 Panel Discussion
13:30-14:30 Networking lunch
The keynote speaker from the UK will be Dr Jonathan Sheffield, Chief Executive of the National Institute for Health Research's Clinical Research Network.
Faster, Easier Clinical Research is one of the main priorities for the NIHR, and lessons learned from the implementation of the OK to Ask campaign offer valuable insight for public health policymakers.
A senior manager from AstraZeneca UK will talk about the practicalities of conducting clinical trials, in particular the relationship between pharmaceutical companies, research institutes, hospitals, doctors – and most important – patients.
GCP PL, the association for pharmaceutical companies engaged in clinical trials in Poland, will present the practical issues facing its members in their day-to-day activities.
The event is addressed to key decision makers in the Polish Ministry of Health and National Health Fund, hospital directors and other personnel involved in the administration of clinical trials from the public-sector side.
There will be a panel discussion offering ample opportunities for exchange of views between public and private sector, Polish and UK practitioners, and questions and comments from the floor.
Full simultaneous translation will be provided.
RSVP: marta.chmielewska@bpcc.org.pl
Media partner:
